-
公开(公告)号:EP2734552B1
公开(公告)日:2024-11-13
申请号:EP12735916.4
申请日:2012-07-20
-
公开(公告)号:EP3858850B1
公开(公告)日:2024-02-28
申请号:EP19866300.7
申请日:2019-09-13
发明人: ARZAMASCEV, Yevgeniy Veniaminovich , AZMUKO, Andrey Andreevich , BUSHUEV, Valeri Nikolaevich , KAZAKOVA, Olga Alekseevna , MOLOKOEDOV, Aleksandr Sergeevich , OVCHINNIKOV, Mihail Vladimirovich , PALKEEVA, Marina Yevgenievna , SIDOROVA, Mariya Vladimirovna , SAMSONOV, Mikhail Vasilievich , TEREKHOVA, Olga Alexandrovna , KHAPCHAEV, Asker Yusufovich , SHIRINSKY, Vladimir Pavlovich
-
公开(公告)号:EP4243824A1
公开(公告)日:2023-09-20
申请号:EP21805547.3
申请日:2021-11-12
申请人: Pharvaris GmbH
发明人: LESAGE, Anne , LU, Peng
IPC分类号: A61K31/4709 , A61K45/06 , A61P7/10 , A61K31/496
-
4.
公开(公告)号:EP4197534A1
公开(公告)日:2023-06-21
申请号:EP22212304.4
申请日:2022-12-08
发明人: Park, Phil June , Kim, Hyunsoo , Choi, Sowoong , Kim, Hyoung June
IPC分类号: A61K31/351 , A61K31/7016 , A61P3/04 , A61P7/10 , A61K8/00
摘要: Provided are a reelin and/or VEGF-C production and/or activation promoter including a compound represented by Chemical Formula 1 or a salt thereof as an active ingredient, and a skin external composition including the same.
(In Chemical Formula 1, each substituent is as defined in the specification.)-
5.
公开(公告)号:EP4090427A1
公开(公告)日:2022-11-23
申请号:EP21704072.4
申请日:2021-01-12
发明人: NURSE, Christina , HAO, Xinming
IPC分类号: A61P7/10 , C07K16/40 , A61K39/395
-
6.
公开(公告)号:EP2413913B1
公开(公告)日:2022-05-18
申请号:EP10714386.9
申请日:2010-03-31
-
7.
公开(公告)号:EP3992198A1
公开(公告)日:2022-05-04
申请号:EP20867092.7
申请日:2020-06-04
发明人: WEI, Nongnong , JIN, Hua , ZHENG, Yongyong , ZHOU, Feng , HUANG, Meihua
IPC分类号: C07F9/58 , A61K31/675 , A61P7/10
摘要: The present invention relates to the technical field of biomedicine, particularly to a pyridine sulfonamide phosphate compound, a preparation method therefor, and a use thereof. The invention provides the following technical benefits: the pyridine sulfonamide phosphate compound has characteristics of high solubility, high stability, ease of being made into preparations, etc., which is easy to be industrially scaled up for medical use.
-
公开(公告)号:EP2976062B1
公开(公告)日:2021-11-03
申请号:EP14722905.8
申请日:2014-03-21
-
公开(公告)号:EP3873463A1
公开(公告)日:2021-09-08
申请号:EP19877809.4
申请日:2019-11-01
IPC分类号: A61K31/415 , A61K31/395 , A61K31/41 , A61P5/48 , A61P7/10 , C07D231/02
-
公开(公告)号:EP3858850A1
公开(公告)日:2021-08-04
申请号:EP19866300.7
申请日:2019-09-13
发明人: ARZAMASCEV, Yevgeniy Veniaminovich , AZMUKO, Andrey Andreevich , BUSHUEV, Valeri Nikolaevich , KAZAKOVA, Olga Alekseevna , MOLOKOEDOV, Aleksandr Sergeevich , OVCHINNIKOV, Mihail Vladimirovich , PALKEEVA, Marina Yevgenievna , SIDOROVA, Mariya Vladimirovna , SAMSONOV, Mikhail Vasilievich , TEREKHOVA, Olga Alexandrovna , KHAPCHAEV, Asker Yusufovich , SHIRINSKY, Vladimir Pavlovich
摘要: The invention relates to a low-toxicity, proteolysis-resistant biologically active nonapeptide of formula (I) that is capable of preventing vascular hyperpermeability in stressful situations. Owing to said property, the claimed peptide can be used in medicine as an anti-edematous agent.
-
-
-
-
-
-
-
-
-